Veeva Systems Inc.
HealthcareNYSE:VEEV · New York Stock Exchange
-$2.58 today
Vol 1.90M · Avg 3.36M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
12.6%
avg 14.2%
ROIC
9.5%
avg 12.6%
ROA
10.1%
avg 10.7%
Analysis
ROE is currently the strongest return metric at 12.6% versus its period average of 14.2%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Brian Van Wagener | Chief Financial Officer | $470,833.00 | — | 43 | $0.00 | <0.01% |
Peter Gassner | Founder, Chief Executive Officer & Director | $470,833.00 | — | 61 | $2.65M | 1.63% |
Thomas D. Schwenger | President & Chief Customer Officer | $470,833.00 | — | 58 | $11,628.00 | <0.01% |
Eleni Nitsa Zuppas | President & Chief of Staff | $470,833.00 | — | 56 | $8,721.00 | <0.01% |
Jonathan W. Faddis | Senior Vice President, General Counsel & Corporate Secretary | $470,833.00 | — | 54 | $6,541.00 | <0.01% |
Catherine Allshouse | Chief Information Officer | — | — | — | — | — |
Gunnar Georg Hansen | Director of Investor Relations | — | — | — | — | — |
Paul Shawah | Executive Vice President of Strategy & Campaign Manager | — | — | — | $14,938.00 | <0.01% |
Vipin Kondath | Chief Accounting Officer | — | — | 50 | $5,884.00 | <0.01% |
Vivian Welsh | Chief People Officer | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
11
$5.58M
Net Sentiment
$5.58M
Net selling
Most Active
Hung Priscilla
4 transactions
1–10 of 11
Analysis
Insiders reported 0 buys worth $0.00 and 11 sells worth $5.58M over the last 12 months. That adds up to net selling of $5.58M. Hung Priscilla was the most active insider with 4 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +136.3% | +27.5% (15yr)5 analysts |
| Revenue | N/A | N/A | +46.7% | +19.2% (15yr)7 analysts |
| Net Income | N/A | N/A | +150.1% | +28.8% (15yr)7 analysts |
| EBIT | N/A | N/A | +37.8% | +21.0% (15yr)7 analysts |
Analysis
Recent growth has been strongest in Net Income at +150.1% over three years. Forward estimates point to Net Income at +28.8% (15yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
argenx SE
NASDAQ:ARGX
$55.58B
Becton, Dickinson and Company
NYSE:BDX
$52.91B
Cardinal Health, Inc.
NYSE:CAH
$52.52B
Edwards Lifesciences Corporation
NYSE:EW
$48.93B
IDEXX Laboratories, Inc.
NASDAQ:IDXX
$44.15B
Haleon plc
NYSE:HLN
$40.37B
Agilent Technologies, Inc.
NYSE:A
$36.57B
IQVIA Holdings Inc.
NYSE:IQV
$29.93B
GE HealthCare Technologies Inc.
NASDAQ:GEHC
$29.57B
Bruker Corporation
NASDAQ:BRKR
$8.17B
Who manages VEEV?
Veeva Systems Inc. (VEEV) lists 10 active executives. The top listed executive is Catherine Allshouse, Chief Information Officer.
Are VEEV insiders buying or selling?
Recent insider activity shows net buying of $4.71M.
Explore More
Continue the stock analysis
Jump to another research area for this company.